Article Information
History
- September 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jessica B. Graham1,
- Jessica L. Swarts1,
- Sarah R. Leist2,
- Alexandra Schäfer2,
- Vineet D. Menachery2,3,
- Lisa E. Gralinski2,
- Sophia Jeng4,5,
- Darla R. Miller6,7,
- Michael A. Mooney5,8,
- Shannon K. McWeeney4,5,8,
- Martin T. Ferris6,
- Fernando Pardo-Manuel de Villena6,7,
- Mark T. Heise6,7,
- Ralph S. Baric2,† and
- Jennifer M. Lund1,9,†,*
- 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
- 2Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
- 3Department of Microbiology and Immunology, University of Texas Medical Center, Galveston, TX
- 4OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR
- 5Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR
- 6Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC
- 7Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
- 8Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR
- 9Department of Global Health, University of Washington, Seattle, WA
- ↵*Corresponding author: Jennifer M. Lund, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, E5-110, Seattle, WA, 98109 U.S.A., Phone number: +1-206-667-2217, Fax Number: +1-206-667-7767, E-mail: jlund{at}fredhutch.org
↵† These authors contributed equally to the work
Posted September 21, 2020.
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection
